Novel approaches for treating hypertension [version 1; referees: 2 approved]

by Andrew J. Freeman, Antony Vinh, Robert E. Widdop
Published 2017-01-01

Influence of Angiotensin II Subtype 2 Receptor (AT2R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subt...

by Emma S. Jones, M. Jane Black, Robert E. Widdop
Published 2012-01-01

Optimising the photothrombotic model of stroke in the C57BI/6 and FVB/N strains of mouse

by Adriana Knezic, Brad R. S. Broughton, Robert E. Widdop, Claudia A. McCarthy
Published 2022-05-01

Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice.

by Zihui Wei, Iresha Spizzo, Henry Diep, Grant R Drummond, Robert E Widdop, Antony Vinh
Published 2014-01-01

Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice

by Yifang Li, Amlan Chakraborty, Brad R.S. Broughton, Dorota Ferens, Robert E. Widdop, Sharon D. Ricardo, Chrishan S. Samuel
Published 2021-12-01

Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats.

by Claudia A McCarthy, Antony Vinh, Alyson A Miller, Anders Hallberg, Mathias Alterman, Jennifer K Callaway, Robert E Widdop
Published 2014-01-01

Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo.

by Seyoung Lee, Megan A Evans, Hannah X Chu, Hyun Ah Kim, Robert E Widdop, Grant R Drummond, Christopher G Sobey
Published 2015-01-01

Morphology and Function of the Lamb Ileum following Preterm Birth

by Tracey J. Flores, Vivian B. Nguyen, Robert E. Widdop, Megan R. Sutherland, Graeme R. Polglase, Helen E. Abud, Mary Jane Black
Published 2018-01-01

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors

by Daniel eClayton, Iresha eHanchapola, Walter Glen Thomas, Robert eWiddop, Alexander Ian Smith, Patrick ePerlmutter, Marie-Isabel eAguilar
Published 2015-01-01

The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice

by Yan Wang, Jonathan Yodgee, Mark Del Borgo, Iresha Spizzo, Levi Nguyen, Marie-Isabel Aguilar, Kate M. Denton, Chrishan S. Samuel, Robert E. Widdop
Published 2022-11-01

The protective effects of a novel AT2 receptor agonist, β-Pro7Ang III in ischemia-reperfusion kidney injury

by Tingfang Zhang, Yifang Li, Andrea F. Wise, Ketav Kulkarni, Marie-Isabel Aguilar, Chrishan S. Samuel, Mark Del Borgo, Robert E. Widdop, Sharon D. Ricardo
Published 2023-05-01

Anti-fibrotic Potential of AT2 Receptor Agonists

by Yan Wang, Mark Del Borgo, Huey W. Lee, Dhaniel Baraldi, Baydaa Hirmiz, Tracey A. Gaspari, Kate M. Denton, Marie-Isabel Aguilar, Chrishan S. Samuel, Robert E. Widdop
Published 2017-08-01

Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats

by Mandy Li, Levi Nguyen, Dorota Ferens, Iresha Spizzo, Yan Wang, Kate M. Denton, Mark Del Borgo, Ketav Kulkarni, Marie-Isabel Aguilar, Chengxue Helena Qin, Chrishan S. Samuel, Tracey A. Gaspari, Robert E. Widdop
Published 2023-09-01

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experime...

by Fariha Alam, Tracey A. Gaspari, Barbara K. Kemp-Harper, Edward Low, Aaron Aw, Dorota Ferens, Iresha Spizzo, Ann-Maree Jefferis, Praveen Praveen, Robert E. Widdop, Ross A.D. Bathgate, Mohammed Akhter Hossain, Chrishan S. Samuel
Published 2023-04-01